Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
- 1 May 2014
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 113 (9) , 1487-1493
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Contrast-Induced Acute Kidney InjuryCirculation, 2010
- Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trialNephrology Dialysis Transplantation, 2009
- Preventing contrast-induced nephropathy: problems, challenges and future directionsBMC Medicine, 2009
- Serious renal dysfunction after percutaneous coronary interventions can be predictedAmerican Heart Journal, 2008
- Epidemiology and Prognostic Implications of Contrast-Induced NephropathyThe American Journal of Cardiology, 2006
- Preventing Nephropathy Induced by Contrast MediumNew England Journal of Medicine, 2006
- Impact of renal insufficiency on outcome after contemporary percutaneous coronary interventionAmerican Heart Journal, 2006
- Impact of nephropathy after percutaneous coronary intervention and a method for risk stratificationThe American Journal of Cardiology, 2004
- Percutaneous coronary intervention‐associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinineCatheterization and Cardiovascular Interventions, 2003
- Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary InterventionCirculation, 2002